Many biotech companies come and go with hype and disappointment.
Why? They are just not good enough to get FDA approval for commercialisation.
How about RAP?
No one can deny ( some of you still but ) this biotech company will make good profit once FDA approval issued.
Also resapp has huge potential for all around the world from USA to China.
Now, whats the most important thing to consider investing on RAP?
Answer: Possibility of FDA approval.
What leads us to FDA approval?
Answer : US trials result.
Below is the answer from Brian yesterday.
Also, during 120 days waiting peroid, what can we expect from the management?
The market wants news..
And Brian said....
Cheers
M2C
Many biotech companies come and go with hype and disappointment....
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #